Novo Nordisk Board Exodus: Chairman & 6 Directors Depart
Danish pharmaceutical giant Novo Nordisk faces major leadership shakeup as chairman and six board members step down following unprecedented growth of weight-loss drug Wegovy.
Category : Search result: pharmaceutical research
Moderna's Oxfordshire vaccine centre gets green light
In a landmark development for UK life sciences, Moderna's cutting-edge mRNA vaccine research centre is coming to Oxfordshire, creating hundreds of jobs and cementing Britain's position in global healthcare innovation.
Trump's Ozempic Remark Hits Pharma Stocks
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Trump's Ozempic Price Pledge Shakes Pharma Markets
Former President Donald Trump pledges to slash prices of weight-loss drugs Ozempic and Wegovy, sending pharmaceutical stocks tumbling and sparking healthcare debate.
California declares emergency over insulin prices
Governor Gavin Newsom takes unprecedented action against pharmaceutical giants as insulin prices soar, making California first US state to produce its own affordable medication.
Trump's FDA Win: IVF Drug Approved Despite Opposition
In a significant political victory, Donald Trump secures FDA approval for Washington's IVF medication, overcoming fierce opposition and setting new healthcare precedents.
New weight loss jab shows unprecedented 24% reduction
Breakthrough drug Retatrutide demonstrates remarkable 24% weight loss in clinical trials, potentially revolutionising obesity treatment in the UK healthcare landscape.
J&J Pays $700M in Talc Cancer Scandal Settlement
Pharmaceutical giant Johnson & Johnson agrees to pay $700 million settlement amid allegations their talcum powder contained asbestos and caused ovarian cancer in thousands of women.
Johnson & Johnson Faces UK Lawsuit Over Talc Cancer Claims
Global pharmaceutical giant Johnson & Johnson is confronting a major class action lawsuit in the UK, with dozens of women alleging its talc-based products caused their cancers. The legal battle could set a crucial precedent for consumer safety.
Johnson & Johnson £50B talc cancer settlement
Pharmaceutical giant Johnson & Johnson agrees to pay £50 billion to settle claims its talcum powder caused cancer, while continuing to deny product safety concerns.
WHO Alert: Contaminated Cough Syrups Linked to Child Deaths
The World Health Organization issues urgent global warning after contaminated cough syrups are connected to dozens of child fatalities across several nations. Health authorities worldwide are scrambling to remove dangerous medications from circulation.
Opium painkiller returns to England and Wales after 50 years
In a landmark pharmaceutical reversal, the opium-based pain medication Opium is set to be reintroduced in England and Wales after being withdrawn from the market nearly five decades ago, offering new hope for chronic pain sufferers.
Science in Crisis: CSIRO Funding Collapse Demands Action
Australia's premier scientific organisation, CSIRO, confronts an existential threat as chronic underfunding triggers brain drain and research cuts. Scientific leaders issue urgent plea to Prime Minister Albanese to rescue national science capability.
Native Americans denied diabetes drugs amid weight loss craze
Native American communities face critical shortages of diabetes medications like Ozempic as wealthy New Yorkers exploit prescriptions for weight loss, creating a healthcare crisis for vulnerable populations.
London Scientists Develop Revolutionary RNA Cancer Test
Groundbreaking research from London's Institute of Cancer Research develops new RNA-based testing method that could revolutionise how we detect and monitor cancer, offering new hope for patients.
AstraZeneca cuts drug prices for NHS in Trump-backed deal
Pharmaceutical giant AstraZeneca agrees to major price reductions on life-saving medications for NHS patients in unprecedented deal supported by former President Trump, promising significant savings for Britain's healthcare system.
Trump pressured AstraZeneca on US drug prices
Exclusive investigation reveals how Donald Trump pressured AstraZeneca to slash US drug prices while keeping UK costs high, exposing stark transatlantic healthcare divide.
AstraZeneca to Provide Cancer Drugs to Medicaid Patients
In a groundbreaking healthcare development, AstraZeneca announces it will provide expensive cancer medications to low-income Americans through Medicaid, challenging pharmaceutical industry norms.
Trump Claims AstraZeneca COVID Drug Discount Amid Questions
Former President Donald Trump announces dramatic price reduction for AstraZeneca's COVID-19 antibody treatment, but details remain scarce and verification proves challenging.
Trump: Big Pharma 'held NHS to ransom' on vaccines
Former US President Donald Trump makes explosive allegations about pharmaceutical companies exploiting the NHS during pandemic negotiations, claiming Britain paid 'far more than other countries' for COVID vaccines.
Naked Mole Rats' Anti-Ageing Secret Unlocked
Groundbreaking research reveals how naked mole rats defy ageing through superior DNA repair mechanisms, offering potential breakthroughs for human health and longevity treatments.
Indian pharma execs arrested in cough syrup death scandal
Indian authorities have detained three pharmaceutical executives following an investigation into contaminated cough syrup allegedly responsible for numerous child deaths in Cameroon.
Colchester research exposes UK business advice failures
Groundbreaking study reveals nearly half of UK businesses receive inadequate professional guidance, with devastating financial consequences for SMEs nationwide.
Harvard-MIT natural molecule breakthrough in cancer fight
Groundbreaking research from Harvard and MIT reveals how a naturally occurring molecule could transform cancer treatment, offering new hope for patients worldwide.
Trump's NHS Trade Deal Bombshell Exposed
Exclusive investigation reveals Donald Trump's plans to put NHS on the table in US trade negotiations, raising alarm about drug prices and American corporate influence on Britain's healthcare system.
Trump Tariffs Threaten NHS Drug Price Crisis
Former President Donald Trump's proposed tariffs could dramatically increase costs for NHS medicines, potentially costing the health service billions and threatening patient care across the UK.
RFK Jr's Bizarre Ozempic Sugar Conspiracy Theory
Independent presidential candidate Robert F. Kennedy Jr has sparked controversy by suggesting diabetes and weight-loss medications like Ozempic are part of a conspiracy to eliminate sugar from American diets. His unconventional claims about artificial swe
Trump Tariffs Threaten NHS Drug Price Crisis
Exclusive investigation reveals how proposed US import tariffs could send NHS drug costs soaring, potentially creating treatment delays and budget crises for Britain's healthcare system.
Eight children die from contaminated cough syrup in India
Shocking investigation reveals eight young children died after consuming contaminated cough syrup in India's Madhya Pradesh region, raising serious questions about pharmaceutical safety standards.
Viral 'Blinking White Guy' GIF Transforms MS Research
Groundbreaking multiple sclerosis research reveals why the famous 'Blinking White Guy' GIF resonates with MS patients, offering new insights into neurological symptoms and brain function.
Page 1 of 4